1,3-(S)-BIS-(CARBXYMETHYL)-9-[1'(S)-3'-ACETYLAMIDE-2'-PHENYLETHYL]-2,5,7-TRIOXO-1,4,8-TRIAZADECANE
Compound with spectra: 1 NMR
![1,3-(S)-BIS-(CARBXYMETHYL)-9-[1'(S)-3'-ACETYLAMIDE-2'-PHENYLETHYL]-2,5,7-TRIOXO-1,4,8-TRIAZADECANE](/api/compound/JEO5pCvMEdX.png?ph=true&h=300&w=458 "1,3-(S)-BIS-(CARBXYMETHYL)-9-[1'(S)-3'-ACETYLAMIDE-2'-PHENYLETHYL]-2,5,7-TRIOXO-1,4,8-TRIAZADECANE")
| SpectraBase Compound ID | JEO5pCvMEdX |
|---|---|
| InChI | InChI=1S/C21H26N4O8/c1-13(26)22-16(9-14-5-3-2-4-6-14)25-8-7-24(12-20(31)32)21(33)15(10-19(29)30)23-17(27)11-18(25)28/h2-6,15-16H,7-12H2,1H3,(H,22,26)(H,23,27)(H,29,30)(H,31,32)/t15-,16+/m0/s1 |
| InChIKey | MKZQDTAGTWCVHS-JKSUJKDBSA-N |
| Mol Weight | 462.46 g/mol |
| Molecular Formula | C21H26N4O8 |
| Exact Mass | 462.175064 g/mol |
| Enantiomer InChIKey | MKZQDTAGTWCVHS-CVEARBPZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
1-(TERT.-BUTYLOXYCARBONYLMETHYL)-(3S)-CYCLOHEXYLOXYCARBONYLMETHYL-9-[2'(S)-3'-PHENYLPROPIONAMIDE]-2,5,7-TRIOXO-1,4,8-TRIAZADECANE
(3S,8AS)-2,3-DIBENZYLTETRAHYDROPYRROLO-[1,2-A]-PYRAZINE-1,6-DIONE
METHYL-(2R)-(3-BUTENYL-[[(2S)-1-(2,2,2-TRIFLUOROACETYL)-TETRAHYDRO-1H-PYRROL-2-YL]-CARBONYL]-AMINO)-3-PHENYLPROPANOATE
MIYAKAMIDE-B2;N-ACETYL-L-TYROSYL-N-METHYL-L-PHENYLALANYL-(ALPHA-E)-ALPHA,BETA-DIDEHYDROTRYPTAMINE
MIYAKAMIDE-B1;N-ACETYL-L-TYROSYL-N-METHYL-L-PHENYLALANYL-(ALPHA-Z)-BETA-DIDEHYDROTRYPTAMINE;TRANS-AMIDE
CARMABIN_A;MAJOR_CONFORMER
CARBAMIN-B
BENZYLOXYCARBONYL-GLYCIN-PROLIN-PROLIN-GLYCIN-ALANIN-GLYCIN-O-BENZYLPEPTIDE
CYCLO-(GLY-ASP-LEU-THR-VAL-TYR-PHE)
1H-Pyrrole-2,5-dione, dihydro-3-[4-(2-hydroxyphenyl)-1-piperazinyl]-1-(5-methyl-3-isoxazolyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Ni-to-Ni + 3-Ethylene-Bridged Partially Modified Retro-Inverso Tetrapeptide β-Turn Mimetic: Design, Synthesis, and Structural Characterization | The Journal of Organic Chemistry | 2002 |